- Home
- KOD vs QTRX Comparison
KOD vs QTRX Comparison
Compare KOD & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- QTRX
- Stock Information
- Founded
- KOD 2009
- QTRX 2007
- Country
- KOD United States
- QTRX United States
- Employees
- KOD N/A
- QTRX N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- KOD Health Care
- QTRX Industrials
- Exchange
- KOD Nasdaq
- QTRX Nasdaq
- Market Cap
- KOD 198.4M
- QTRX 233.5M
- IPO Year
- KOD 2018
- QTRX 2017
- Fundamental
- Price
- KOD $8.84
- QTRX $5.85
- Analyst Decision
- KOD Hold
- QTRX Buy
- Analyst Count
- KOD 3
- QTRX 4
- Target Price
- KOD $9.00
- QTRX $13.50
- AVG Volume (30 Days)
- KOD 549.8K
- QTRX 691.9K
- Earning Date
- KOD 08-13-2025
- QTRX 08-07-2025
- Dividend Yield
- KOD N/A
- QTRX N/A
- EPS Growth
- KOD N/A
- QTRX N/A
- EPS
- KOD N/A
- QTRX N/A
- Revenue
- KOD N/A
- QTRX $135,688,000.00
- Revenue This Year
- KOD N/A
- QTRX N/A
- Revenue Next Year
- KOD N/A
- QTRX $14.28
- P/E Ratio
- KOD N/A
- QTRX N/A
- Revenue Growth
- KOD N/A
- QTRX 7.71
- 52 Week Low
- KOD $1.92
- QTRX $4.05
- 52 Week High
- KOD $11.60
- QTRX $16.01
- Technical
- Relative Strength Index (RSI)
- KOD 84.50
- QTRX 50.18
- Support Level
- KOD $5.00
- QTRX $5.09
- Resistance Level
- KOD $5.73
- QTRX $5.84
- Average True Range (ATR)
- KOD 0.70
- QTRX 0.38
- MACD
- KOD 0.42
- QTRX -0.05
- Stochastic Oscillator
- KOD 99.61
- QTRX 48.41
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.